Resumo

TALAVERA, Gricelda et al. Intestinal Colonization by Vancomycin-Resistant Enterococci in Cancer Patients with Risk Factors. Pediatr. (Asunción) [online]. 2011, vol.38, n.2, pp.123-125. ISSN 1683-9803.

The study objectives were to determine the prevalence of intestinal colonization by vancomycin-resistant enterococci (VRE) in cancer patients with risk factors and describe their clinical and demographic characteristics. A longitudinal study conducted between December 1, 2008 and March 30, 2010, in patients aged ≤18 years. A total of 33 patients were included. VRE were isolated in 94% (31/33), of whom 39% (12/31) were age 10-14 years. 58% (18/31) were male, and 21/31 presented acute lymphoblastic leukemia (ALL). All had previously received antibiotics, 90% (28/31) vancomycin. 84% (26/31) had central venous catheters (CVC), 2/31 had surgery, and 1/31 MV. Contact precautions were implemented. In conclusion, a high rate of VRE colonization was observed. CVC and use of vancomycin were predominant. It is important to continue the established measures, monitoring, and the prudent use of vancomycin.

Palavras-chave : Vancomycin-resistant enterococci; intestinal colonization; cancer patients; pediatrics.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )